We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diagnostic Value of C-reactive Protein and White Blood Cell Counts for Early Detection of Inflammatory Complications After Open Resection of Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01221324
Recruitment Status : Completed
First Posted : October 15, 2010
Last Update Posted : February 13, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) and white blood cell counts (WBC) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP and WBC for postoperative inflammatory complications after open resection of colorectal cancer.

Condition or disease
Given Indication for Open Resection of Colorectal Cancer

Study Design

Study Type : Observational
Actual Enrollment : 1200 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : November 2010
Primary Completion Date : November 2010
Study Completion Date : November 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Patients after open resection of colorectal cancer


Outcome Measures

Primary Outcome Measures :
  1. postoperative inflammatory complications [ Time Frame: 30 days ]

Secondary Outcome Measures :
  1. Anastomotic leakage [ Time Frame: 60 days ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Given indication for resection of colorectal cancer
Criteria

Inclusion Criteria:

  • all patients with resection of colorectal cancer

Exclusion Criteria:

  • lack of measurement of C-reactive protein
  • lack of measurement of white blood cell counts
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01221324


Sponsors and Collaborators
Cantonal Hospital of St. Gallen
Investigators
Principal Investigator: Rene Warschkow, MD Cantonal Hospital St. Gallen
More Information

Publications:
Responsible Party: Ignazio Tarantino, M.D., Cantonal Hospital of St. Gallen
ClinicalTrials.gov Identifier: NCT01221324     History of Changes
Other Study ID Numbers: EKSG10/126
First Posted: October 15, 2010    Key Record Dates
Last Update Posted: February 13, 2012
Last Verified: February 2012

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases